Ebola vaccine

all catalysts(0)

nothing on the calendar yet

News(10)

• The main therapy used for children with autism faces changes under Medicaid
  Quid-pro-quo vaping policies, ebola vaccine efforts, and more health news from Morning Rounds
  stat · 6d ago
• FDA panel confronting peptide controversy
  Today's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and data on Lilly's "triple-G."
  stat · 19d ago
• New study supports testing of Merck’s Ebola vaccine in DRC outbreak
  New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses, could also offer some protection against another.
  stat · 20d ago
• Agenus surges on study pivot; Apnimed lines up an IPO
  Agenus is financially abandoning an ongoing study in late-line colorectal cancer. Elsewhere, an ebola vaccine began human testing and an important Bristol Myers medicine got an FDA decision date.
  biopharma_dive · 29d ago
• STAT+: Pharmalittle: We’re reading about Roche accusing U.S. of ‘blackmail,’ a ruling on skinny labels, and more
  Drugmakers and patient groups asked the FDA to pause former commissioner Marty Markary's National Priority Voucher drug review program
  stat · 2mo ago
• STAT+: Supreme Court backs generic drugmaker in ‘skinny labeling’ case
  The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with implications for lawsuits over so-called skinny labels.
  stat · 2mo ago
• STAT+: For pancreatic cancer patients, an exciting drug can feel out of reach
  For pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might get the treatment or if there will be enough…
  stat · 2mo ago
• STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and more
  Eli Lilly is halving its originally planned investment in the production of weight loss syringes in Germany in response to a cost-cutting law
  stat · 2mo ago
• STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
  Taking weight loss drugs for at least three years could prevent thousands of knee replacements a year, a new study found
  stat · 2mo ago
• Senior NIH scientist, research fellow charged with bringing deactivated mpox virus into U.S.
  A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it.
  stat · 2mo ago